These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 6486830

  • 21. Expression and partial characterization of estramustine-binding protein (EMBP) in human breast cancer and malignant melanoma.
    Björk P, Borg A, Fernö M, Nilsson S.
    Anticancer Res; 1991; 11(3):1173-82. PubMed ID: 1888147
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA, Chantada Abal V, Lamas Meilan AC, González Martín M.
    Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
    [No Abstract] [Full Text] [Related]

  • 24. Estramustine. Metabolic pattern and possible mechanisms for its action in prostate cancer.
    Kadohama N, Kirdani RY, Madajewicz S, Murphy GP, Sandberg AA.
    N Y State J Med; 1979 Jun; 79(7):1005-9. PubMed ID: 287893
    [No Abstract] [Full Text] [Related]

  • 25. Estramustine phosphate: metabolic aspects related to its action in prostatic cancer.
    Kadohama N, Kirdani RY, Murphy GP, Sandberg AA.
    J Urol; 1978 Feb; 119(2):234-9. PubMed ID: 633484
    [Abstract] [Full Text] [Related]

  • 26. Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients.
    Hedlund PO, Gustafson H, Sjögren S.
    Scand J Urol Nephrol Suppl; 1980 Feb; 55():103-5. PubMed ID: 6938012
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
    Stridsklev IC, Fosså SD, Kaalhus O.
    Tidsskr Nor Laegeforen; 1984 Oct 10; 104(28):1977-80. PubMed ID: 6388019
    [No Abstract] [Full Text] [Related]

  • 29. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
    Kalland T, Haukaas S.
    Invest Urol; 1981 May 10; 18(8):437-9. PubMed ID: 7228576
    [Abstract] [Full Text] [Related]

  • 30. Metabolic parameters of Estracyt pertinent to its effects in prostatic cancer.
    Sandberg AA.
    Urology; 1984 Jun 10; 23(6 Suppl):11-21. PubMed ID: 6375075
    [No Abstract] [Full Text] [Related]

  • 31. Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma.
    Bergenheim AT, Björk P, Bergh J, von Schoultz E, Svedberg H, Henriksson R.
    Cancer Res; 1994 Sep 15; 54(18):4974-9. PubMed ID: 8069865
    [Abstract] [Full Text] [Related]

  • 32. Estrogen receptor and binding site for estramustine in metastatic malignant melanoma.
    Fernö M, Borg A, Ingvar C, Jönsson PE.
    Anticancer Res; 1987 Sep 15; 7(4B):741-3. PubMed ID: 3314674
    [Abstract] [Full Text] [Related]

  • 33. Oral estramustine phosphate (Estracyt): a broad phase II study.
    Halpern J, Catane R.
    J Med; 1984 Sep 15; 15(1):35-43. PubMed ID: 6593404
    [Abstract] [Full Text] [Related]

  • 34. [The phase IV studies with Estracyt in prostatic cancer].
    Ohhori T, Kubo T, Akasaka T, Funyu T, Yagihashi Y, Kudo T, Tsuchida S, Harada T, Sasaki S, Orikasa S.
    Hinyokika Kiyo; 1988 Aug 15; 34(8):1493-502. PubMed ID: 3057833
    [Abstract] [Full Text] [Related]

  • 35. Specific binding of estramustine to prostatic proteins.
    Forsgren B, Björk P.
    Urology; 1984 Jun 15; 23(6 Suppl):34-8. PubMed ID: 6375077
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of treatment on the expression of estramustine-binding protein (EMBP) in prostatic cancer patients: an immunohistochemical study.
    Flüchter SH, Nelde HJ, Björk P, Müntzing J, Bichler KH.
    Prostate; 1989 Jun 15; 14(1):27-43. PubMed ID: 2648345
    [Abstract] [Full Text] [Related]

  • 38. Incorporation of 3H-thymidine and 14C-amino acids into the ventral prostate after in vivo treatment with estradiol-3N-BIS(2-chloroethyl)carbamate-17 beta-phosphate (Estracyt) and its estrogen and cytostatic parts.
    Hoisaeter PA.
    Invest Urol; 1976 Sep 15; 14(2):85-92. PubMed ID: 972011
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.